Mon, Sep 1, 2014, 5:48 PM EDT - U.S. Markets closed for Labor Day

Recent

% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

  • yzzycz yzzycz Jan 28, 2013 8:34 PM Flag

    disease that affects less than than 4,000 people in the U.S. per year

    Cambridge-based InVivo Therapeutics Holdings Corp. (NVIV), a developer of spinal cord injury treatments, has filed a request with the U.S. Food and Drug Administration for Humanitarian Use Device (HUD) designation of its biopolymer scaffolding product.

    The FDA designation is for a device that will benefit patients by treating or diagnosing a disease that affects less than than 4,000 people in the U.S. per year. Because a device manufacturer’s research and development costs may be highert than its market returns, the HUD provision provides an incentive for the development of devices.

    Sentiment: Strong Sell

 
NVIV
0.620.00(+0.73%)Aug 29 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yahoo! Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Avago Technologies Limited
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT